Extrait

Evaluation of maintenance BCG immunotherapy (dose 27 mg) in superficial bladder tumors. Two randomized arms (every 3 or 6 months) will be studied for a population of 300 patients.

Critère d'inclusion

• bladder cancer

Liens

• ictrp
• nct